Company

PharmaZac is one of the most dynamic pharmaceutical firms in Greece and an important player in manufacturing, exports and healthcare.

Research & Development

PharmaZac is investing more than 15% of its annual income on new products, technologies and infastructure.

Operations

We understand how a modern Pharmaceutical company should function. PharmaZac provides a full array of services from Sales, Marketing and Business Development to Distribution & Logistics.

Products

PharmaZac offers a wide range of more than 90 products in the therapeutic areas of Cardiology, Oncology, CNS, Urology, Dermatology, Contrast Media, Antibiotics & Orthopaedics.

Latest News
  • Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. Hypercalemia in adults patients with Parathyroid Carcinoma (PC) and Hypercalemia in adults patient with primary......

  • We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac iw happy to announce that it will begin in December ΄20 the distribution of the products of KRKA and TAD in Greece. KRKA is a global leader in healthcare with......

  • We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of Lamia (Greece) we will be fully operational from Q3/2021. We are hosting a state-of-the-art Cyclotron in a newly built......

  • With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more than 165 meetings at CPhI festival, EuroPLX and PHARMA SYNERGY.  ...

35

Years of Research & Development

12

Business Units

4

European Awards

5

Global Certifications

Memberships & Awards

  • Pharmazac is a proud member of the Hellenic Pharmaceutical Industry Association with an active intervention in policy making and regulatory changes.
  • Pharmazac is regularly inspected by the Authorities and International Clients for its logistics, distribution and wholesale commercial best practices. In 2016 the company’s GDP has been renewed.
  • As a permanent member of the Generics Association Pharmazac has joined the working committees and is an active participant.
  • The implementation of Good Manufacturing Practice is certified by local and international authorities while a robust QA system suns through the company’s operations.
  • Pharmazac first received an ISO Certificate in 1997 and has been audited without interruption since then.
  • Pharmazac is a regular member of Hellenic Association of Pharmaceutical Companies

Cooperations

We are getting bigger
Are you interested in working in an awarded pharmaceutical company?